Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
DB01288ApprovedWithdrawnSmall molecule
Fenoterol is a beta-2 adrenergic agonist and bronchodilator used for the symptomatic treatment of asthma.
- Mechanism
- Curator reviewed
Beta(2)-receptor stimulation in the lung causes relaxation of bronchial smooth muscle, bronchodilation, and increased bronchial airflow.
- Primary indication
- Fenoterol is used for the treatment of asthma.Curator reviewed · 4 structured indications
- Formula / weight
- C17H21NO4 · 303.3529 g/mol (avg)
- First approval
- Canada, 1995
- Also known as
- Phenoterol
- Code names
- TH-1165
Resolves to
Clinical / RWD
Structure
InChIKey
LSLYOANBFKQKPT-UHFFFAOYSA-NSMILESCC(CC1=CC=C(O)C=C1)NCC(O)C1=CC(O)=CC(O)=C1Transporters
What you can answer from here — as of September 23, 2026
3Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
2TransportersSubstrate / inhibitor direction, not just membership
Listed above
Which drugs share a target with Fenoterol, and which of those have an active Phase 3 trial?